Miura Kotaro, Yagi Ryuichiro, Miyama Hiroshi, Kimura Mai, Kanazawa Hideaki, Hashimoto Masahiro, Kobayashi Sayuki, Nakahara Shiro, Ishikawa Tetsuya, Taguchi Isao, Sano Motoaki, Sato Kazuki, Fukuda Keiichi, Deo Rahul C, MacRae Calum A, Itabashi Yuji, Katsumata Yoshinori, Goto Shinichi
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
EClinicalMedicine. 2023 Aug 17;63:102141. doi: 10.1016/j.eclinm.2023.102141. eCollection 2023 Sep.
Atrial septal defect (ASD) increases the risk of adverse cardiovascular outcomes. Despite the potential for risk mitigation through minimally invasive percutaneous closure, ASD remains underdiagnosed due to subtle symptoms and examination findings. To bridge this diagnostic gap, we propose a novel screening strategy aimed at early detection and enhanced diagnosis through the implementation of a convolutional neural network (CNN) to identify ASD from 12-lead electrocardiography (ECG).
ECGs were collected from patients with at least one recorded echocardiogram at 3 hospitals from 2 continents (Keio University Hospital from July 2011 to December 2020, Brigham and Women's Hospital from January 2015 to December 2020, and Dokkyo Medical University Saitama Medical Center from January 2010 and December 2021). ECGs from patients with a diagnosis of ASD were labeled as positive cases while the remainder were labeled as negative. ECGs after the closure of ASD were excluded. After randomly splitting the ECGs into 3 datasets (50% derivation, 20% validation, and 30% test) with no patient overlap, a CNN-based model was trained using the derivation datasets from 2 hospitals and was tested on held-out datasets along with an external validation on the 3rd hospital. All eligible ECGs were used for derivation and validation whereas the earliest ECG for each patient was used for the test and external validation. The discrimination of ASD was assessed by the area under the receiver operating characteristic curve (AUROC). Multiple subgroups were examined to identify any heterogeneity.
A total of 671,201 ECGs from 80,947 patients were collected from the 3 institutions. The AUROC for detecting ASD was 0.85-0.90 across the 3 hospitals. The subgroup analysis showed excellent performance across various characteristics Screening simulation using the model greatly increased sensitivity from 80.6% to 93.7% at specificity 33.6% when compared to using overt ECG abnormalities.
A CNN-based model using 12-lead ECG successfully identified the presence of ASD with excellent generalizability across institutions from 2 separate continents.
This work was supported by research grants from JST (JPMJPF2101), JSR corporation, Taiju Life Social Welfare Foundation, Kondou Kinen Medical Foundation, Research fund of Mitsukoshi health and welfare foundation, Tokai University School of Medicine Project Research and Internal Medicine Project Research, Secom Science and Technology Foundation, and Grants from AMED (JP23hma922012 and JP23ym0126813). This work was partially supported by One Brave Idea, co-funded by the American Heart Association and Verily with significant support from AstraZeneca and pillar support from Quest Diagnostics.
房间隔缺损(ASD)会增加不良心血管结局的风险。尽管通过微创经皮封堵有可能降低风险,但由于症状和检查结果不明显,ASD仍未得到充分诊断。为了弥补这一诊断差距,我们提出了一种新颖的筛查策略,旨在通过实施卷积神经网络(CNN)从12导联心电图(ECG)中识别ASD,以实现早期检测和强化诊断。
从来自2个大陆的3家医院收集了至少有一次记录的超声心动图的患者的心电图(庆应义塾大学医院,2011年7月至2020年12月;布莱根妇女医院,2015年1月至2020年12月;埼玉医科大学国际医疗中心,2010年1月至2021年12月)。诊断为ASD的患者的心电图被标记为阳性病例,其余的被标记为阴性。ASD封堵术后的心电图被排除。在将心电图随机分为3个数据集(50%用于推导,20%用于验证,30%用于测试)且无患者重叠后,使用来自2家医院的推导数据集训练基于CNN的模型,并在保留数据集上进行测试,同时在第3家医院进行外部验证。所有符合条件的心电图用于推导和验证,而每个患者最早的心电图用于测试和外部验证。通过受试者操作特征曲线下面积(AUROC)评估ASD的辨别能力。检查多个亚组以确定任何异质性。
从这3家机构共收集了80947名患者的671201份心电图。在3家医院中,检测ASD的AUROC为0.85 - 0.90。亚组分析显示在各种特征上表现出色。与使用明显的心电图异常相比,使用该模型进行筛查模拟在特异性为33.6%时,灵敏度从80.6%大幅提高到93.7%。
基于12导联心电图的CNN模型成功识别出ASD的存在,在来自2个不同大陆的机构中具有出色的通用性。
这项工作得到了日本科学技术振兴机构(JPMJPF2101)、JSR公司、太住生命社会福利基金会、近藤纪念医学基金会、三越健康与福利基金会研究基金、东海大学医学院项目研究和内科项目研究、世康科学技术基金会以及日本医疗研究与开发机构(JP23hma922012和JP23ym0126813)的研究资助。这项工作部分得到了“一个勇敢的想法”的支持,该项目由美国心脏协会和Verily共同资助,阿斯利康提供了重要支持,奎斯特诊断公司提供了支柱支持